Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

CDC: Lyme Disease Spread 320 Percent in 19 Years

July 17, 2015 9:28 am | by Seth Augenstein, Digital Reporter | News | Comments

Lyme disease continues to spread outward from two major clusters within the United States – areas of spread gradually enveloping new parts of the country, according to the Centers for Disease Control and Prevention. Read more...

TOPICS:

First Made-In-Singapore Cancer Drug Enters Clinical Testing

July 17, 2015 9:22 am | by Biomedical Sciences Institute | News | Comments

A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the live of cancer patients in Singapore, and worldwide. Read more...

TOPICS:

Improving Treatment for Systemic Amyloidosis

July 17, 2015 8:28 am | by University College London | News | Comments

A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration. Read more...

TOPICS:
Advertisement

EU Approves BMS's HIV-1 Treatment for Adults

July 17, 2015 8:21 am | News | Comments

The approval allows for the marketing of Evotaz in all 28 Member States of the European Union (EU) and offers patients living with HIV an innovative treatment option that delivers proven suppression through 144 weeks. Read more...

TOPICS:

Common Mental Health Drug Could Be Used to Treat Arthritis

July 17, 2015 8:14 am | by Queen Mary University of London | News | Comments

Lithium chloride which is used as a mood stabilizer in the treatment of mental health problems, mainly bipolar disorder, could be used to treat arthritis according to a new study. Read more...

TOPICS:

Union Petitions to End Pharma Funding for CME

July 16, 2015 5:32 pm | by Stephanie Guzowski, Editor | News | Comments

The pharmaceutical industry’s funding of Continuing Medical Education (CME) events has drawn its share of controversy, with some saying that the practice could unfairly influence what a doctor prescribes. Unite Here, a labor union, delivered thousands of petitions to the Accrediting Council for Continuing Medical Education (ACCME) board meeting yesterday in Chicago. Read more..

TOPICS:

National Psoriasis Foundation, Pfizer Launch Partnership for Grants

July 16, 2015 1:43 pm | News | Comments

To increase the number of people with psoriatic disease who are effectively treating their condition and improve their quality of life, the National Psoriasis Foundation and pharmaceutical company Pfizer will award up to $1 million in learning and change grants through a new grant program. Read more...

TOPICS:

Making 'Miniature Brains' from Skin Cells to Better Understand Autism

July 16, 2015 1:34 pm | by Yale University | News | Comments

A larger head size—or macrocephaly—is seen in many children with severe autism spectrum disorder (ASD). A new stem cell study of these children by Yale School of Medicine researchers could help predict ASD and may lead to new drug targets for autism treatment. Read more...

TOPICS:
Advertisement

GSK Begins Shipping 2015-16 U.S. Flu Vaccines

July 16, 2015 1:23 pm | News | Comments

GSK announced today it has begun shipping Fluarix Quadrivalent (Influenza Vaccine) doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research. Read more...

TOPICS:

Child Paralysis Outbreak: UVA Identifies Potential Cause

July 16, 2015 1:15 pm | by University of Virginia | News | Comments

A mysterious outbreak of child paralysis cases previously linked to enterovirus D68 may instead have another cause, doctors at the University of Virginia Children’s Hospital are cautioning after determining that a stricken child appeared to be suffering from a different virus. Read more...

TOPICS:

UnitedHealth Tops Street 2Q Forecasts, Raises Forecasts

July 16, 2015 12:43 pm | by Tom Murphy, AP Business Writer | News | Comments

UnitedHealth continued to juice up its business outside health insurance in a better-than-expected second quarter while rivals scrambled to add enrollment in a wave of mega-mergers sweeping the sector. Read more...

TOPICS:

Device Offers Remote-Controlled Drug Delivery

July 16, 2015 12:27 pm | by Stephanie Guzowski, Editor | News | Comments

A wireless device, demonstrated for the first time in mice, can be implanted in the brain and activated by the remote push of a button to deliver drugs, according to a study published today in the journal Cell. Read more...

TOPICS:

Study: Differences in Brain Wiring Responsible for Different Trauma Recoveries

July 16, 2015 8:58 am | by Seth Augenstein, Digital Reporter | News | Comments

Some young people quickly recover from traumatic brain injuries, while others take much longer to recover – if they ever do at all. The difference appears to be in the brain’s wiring system – and not the overall severity of the injury, according to a new study published in the Journal of Neuroscience Wednesday. Read more...

TOPICS:

Transplant Drug Could Turn the Tide of Heart Attack Damage

July 15, 2015 4:41 pm | News | Comments

New research has revealed how a drug commonly used after transplant operations could limit some of the heart damage caused by a heart attack, in a study from Newcastle University. Read more...

TOPICS:

Oxford Ebola Vaccine Study Moves to Next Phase

July 15, 2015 4:36 pm | by Oxford University | News | Comments

The EBOVAC2 project is funded under a grant from the European Commission’s Innovative Medicine Initiative Ebola+ programme which was launched in response to the Ebola virus disease outbreak. The EBOVAC2 project aims to assess the safety and immunogenicity of a novel prime boost preventative vaccine regimen against Ebola Virus Disease (EVD). Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading